Expertise in
26
conditions

Dr. Edward A. Levine

General Surgery | Surgical Oncology
Wake Forest University Health Sciences
Medical Ctr Blvd, 
Winston Salem, NC 
Accepting New Patients
Expertise in
26
conditions
Wake Forest University Health Sciences
Medical Ctr Blvd, 
Winston Salem, NC 

Overview

Edward Levine is a General Surgeon and a Surgical Oncologist practicing medicine in Winston Salem, North Carolina.

Dr. Levine is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Pseudomyxoma Peritonei, Breast Cancer, Colorectal Cancer, Mastectomy, and Gastrectomy.

He is actively involved in clinical research, co-authoring 246 peer reviewed articles and participating in 8 clinical trials. Dr. Levine is currently accepting new patients.

Specialties

General Surgery
Surgical Oncology

Licenses

Surgery in NC

Hospital Affiliations

North Carolina Baptist Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AmeriHealth
  • EPO
  • HMO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

WAKE FOREST UNIVERSITY HEALTH SCIENCES
Medical Ctr Blvd, Winston Salem, NC 27157

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

ALTernate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant TrEatment (ALTERNATE) in Postmenopausal Women: A Phase III Study
ALTernate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer Neoadjuvant TrEatment (ALTERNATE) in Postmenopausal Women: A Phase III Study
Enrollment Status: Active_not_recruiting
Publish Date: June 05, 2026
Intervention Type: Drug
Study Drugs: Fulvestrant, Anastrozole
Study Phase: Phase 3
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel With or Without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug, Other
Study Drugs: Carboplatin, Cyclophosphamide, Doxorubicin Hydrochloride, Paclitaxel
Study Phase: Phase 3
Exceptional Responders Pilot Study: Molecular Profiling of Tumors From Cancer Patients Who Are Exceptional Responders
Exceptional Responders Pilot Study: Molecular Profiling of Tumors From Cancer Patients Who Are Exceptional Responders
Enrollment Status: Active_not_recruiting
Publish Date: April 17, 2026
Intervention Type: Other
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 10, 2026
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer
Enrollment Status: Completed
Publish Date: December 04, 2025
Intervention Type: Drug, Radiation, Biological
Study Phase: Phase 2
A Phase I Trial of Talimogene Laherparepvec for the Treatment of Peritoneal Surface Malignancies
A Phase I Trial of Talimogene Laherparepvec for the Treatment of Peritoneal Surface Malignancies
Enrollment Status: Completed
Publish Date: November 20, 2024
Intervention Type: Biological
Study Drug: Talimogene Laherparepvec
Study Phase: Phase 1
A Phase 2, Open-Label Study to Evaluate the Performance and Safety of ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peritoneal Mets
A Phase 2, Open-Label Study to Evaluate the Performance and Safety of ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peritoneal Mets
Enrollment Status: Completed
Publish Date: November 08, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint
Enrollment Status: Unknown
Publish Date: January 09, 2019
View 7 Less Clinical Trials

246 Total Publications

ASO Visual Abstract: Next-Generation Sequencing Identifies Key Targetable Mutations in the Treatment of Appendiceal Neoplasms.
ASO Visual Abstract: Next-Generation Sequencing Identifies Key Targetable Mutations in the Treatment of Appendiceal Neoplasms.
Journal: Annals of surgical oncology
Published: May 08, 2026
Similar Doctors
Expertise in
8
conditions
Dr. Marissa M. Howard-Mcnatt
General Surgery | Surgical Oncology
Expertise in
8
conditions
Dr. Marissa M. Howard-Mcnatt
General Surgery | Surgical Oncology
Referral may be required
Before you request

Atrium Health Wake Forest Baptist Hearing And Speech-Clemmons

2341 Lewisville Clemmons Rd, 
Clemmons, NC 
 (7.3 miles away)
336-713-3200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Marissa Howard-Mcnatt is a General Surgeon and a Surgical Oncologist practicing medicine in Clemmons, North Carolina. Dr. Howard-Mcnatt is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Howard-Mcnatt is currently accepting new patients.

Expertise in
29
conditions
Dr. Perry Y. Shen
General Surgery
Expertise in
29
conditions
Dr. Perry Y. Shen
General Surgery
Referral may be required

Office

3 S Hawthorne Rd, 
Winston Salem, NC 
 (1.6 miles away)
336-716-4464
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Perry Shen is a General Surgeon practicing medicine in Winston Salem, North Carolina. Dr. Shen is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Gallbladder Disease, Pancreatectomy, and Hepatectomy. Dr. Shen is currently accepting new patients.

Expertise in
4
conditions
Dr. Eleftherios A. Makris
Surgical Oncology | General Surgery
Expertise in
4
conditions
Dr. Eleftherios A. Makris
Surgical Oncology | General Surgery
Referral may be required

Wake Forest University Health Sciences

Medical Ctr Blvd, 
Winston Salem, NC 
 (0.1 miles away)
336-716-2734
Experience:
17+ years
Languages Spoken:
English
See accepted insurances

Eleftherios Makris is a Surgical Oncologist and a General Surgeon practicing medicine in Winston Salem, North Carolina. He has been practicing medicine for over 17 years. Dr. Makris is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Pancreatic Islet Cell Tumor, Neuroendocrine Tumor, Embryonal Tumor with Multilayered Rosettes, Pancreaticoduodenectomy, and Pancreatectomy.

Frequently Asked Questions about Dr. Edward A. Levine

How do I make an appointment with Dr. Edward A. Levine?

You can book an appointment with Dr. Edward A. Levine by calling their office at 336-716-2734. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Edward A. Levine a top-rated expert for Pseudomyxoma Peritonei?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Edward A. Levine is classified as an Elite expert for Pseudomyxoma Peritonei, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Edward A. Levine specialize in?

While Dr. Edward A. Levine is a General Surgery, they have specific expertise in Pseudomyxoma Peritonei, Breast Cancer, and Colorectal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within General Surgery.

Does Dr. Edward A. Levine participate in research or clinical trials?

Yes. Dr. Edward A. Levine has published 246 articles and abstracts on conditions like Pseudomyxoma Peritonei. You can view a list of Dr. Edward A. Levine's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Edward A. Levine accept my insurance?

Dr. Edward A. Levine accepts most major insurance plans, including Aetna and AmeriHealth. We recommend calling the office directly at 336-716-2734 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Levine's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 16 Advanced Conditions
View All 60 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile